Infectious Diseases Completed Phase 3 Trials for Rivaroxaban (DB06228)

Also known as: Infectious Disease

IndicationStatusPhase
DBCOND0028267 (Infectious Diseases)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02111564A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge PatientsPrevention